APP and Alzheimer disease: With regard to AD, enhancing ADAM10 non-amyloidogenic APP processing could be achieved by stimulation of Tspan12, Tspan15 and Tspan33 using agonistic monoclonal antibodies, sLELs or small molecular drugs that increase the promoter activity and protein expression of these tetraspanins.